3 May 2017 - Deborah Wilkes
Archived
Acquiring Boehringer Ingelheim's Consumer Health Care business lifted worldwide sales at Sanofi Consumer Healthcare by 42.7% at constant exchange rates to EUR1.34 billion (USD1.46 billion) in the first quarter of 2017. Launching Xyzal Allergy 24HR (levocetirizine dihydrochloride) in the US contributed EUR43 million.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.